102.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$100.91
Aprire:
$101.4
Volume 24 ore:
6.01M
Relative Volume:
0.70
Capitalizzazione di mercato:
$151.88B
Reddito:
$19.35B
Utile/perdita netta:
$2.78B
Rapporto P/E:
54.82
EPS:
1.8696
Flusso di cassa netto:
$3.82B
1 W Prestazione:
+3.70%
1M Prestazione:
+7.43%
6M Prestazione:
-0.35%
1 anno Prestazione:
+15.85%
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
102.50 | 149.59B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
127.00 | 218.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.70 | 135.77B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.40 | 118.85B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
85.16 | 48.79B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
CLOSURE-AF study not the end of the line for LAAC devices - BioWorld MedTech
Can Boston Scientific Corporation recover in the next quarter2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Using AI based signals to follow Boston Scientific Corporation2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
What earnings revisions data tells us about Boston Scientific CorporationMarket Trend Review & AI Driven Stock Reports - newser.com
What's Behind Boston Scientific's Optimism for Urology Growth? - Nasdaq
Technical signs of recovery in Boston Scientific CorporationGDP Growth & AI Forecast Swing Trade Picks - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - Quantisnow
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Can Boston Scientific Corporation stock sustain revenue momentumTrade Exit Report & Safe Capital Growth Tips - newser.com
Elutia Q3 2025 slides: $88M Boston Scientific deal reshapes strategy amid revenue dip - Investing.com
Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX) - GuruFocus
Boston Scientific director Zane sells $1.26 million in stock - Investing.com
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corporation (BSX) Stock forecasts - Yahoo! Finance UK
Boston Scientific Corporation (BSX) Stock Forecasts - Yahoo Finance
[144/A] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Can Boston Scientific Corporation stock test all time highsMarket Rally & Weekly Top Stock Performers List - newser.com
Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches - Yahoo Finance
Top FDA clearances not to be missed - Modern Healthcare News
Boston Scientific Corp. (BSX) Stock Price Prediction: 2025, 2026, 2030: Analyst Targets & Forecast - Benzinga
Main Street Research LLC Has $40.96 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Homestead Advisers Corp Has $81.57 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Fullcircle Wealth LLC Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific EVP Joseph Michael Fitzgerald Sells 50,000 Shares - TradingView
Global Pain Management Devices Market Set to Expand Rapidly at a CAGR of ~8% by 2032 Amid Growing Preference for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Bank of New York Mellon Corp Has $1.20 Billion Stake in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock ready for a breakoutJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
[144] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific (NYSE: BSX) to join Wolfe and Citi events; webcasts Nov. 18 and Dec. 2 - Stock Titan
iA Global Asset Management Inc. Buys 9,476 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Machina Capital S.A.S. - MarketBeat
[10-Q] BOSTON SCIENTIFIC CORP Quarterly Earnings Report | BSX SEC FilingForm 10-Q - Stock Titan
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Sumitomo Life Insurance Co. Sells 6,543 Shares of Boston Scientific Corporation $BSX - MarketBeat
Wakefield Asset Management LLLP Purchases New Position in Boston Scientific Corporation $BSX - MarketBeat
October M&A: Bristol Myers, Thermo Fisher, Hologic and Boston Scientific - The Business Journals
Is Boston Scientific Corporation stock a smart buy before Fed meetingWeekly Profit Summary & Verified Swing Trading Watchlist - newser.com
Risk vs reward if holding onto Boston Scientific Corporation2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Do Wall Street Analysts Like Boston Scientific Stock? - MSN
Gould Asset Management LLC CA Takes $1.10 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Position Boosted by Assetmark Inc. - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Atria Investments Inc - MarketBeat
World Investment Advisors Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
What market sentiment indicators show for Boston Scientific Corporation stockM&A Rumor & Safe Entry Zone Identification - newser.com
Boston Scientific Corporation $BSX Shares Sold by GAM Holding AG - MarketBeat
Lockheed Martin Investment Management Co. Lowers Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story? - Insider Monkey
Adell Harriman & Carpenter Inc. Has $4.89 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):